Your browser doesn't support javascript.
loading
Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease.
Risnes, Louise F; Christophersen, Asbjørn; Dahal-Koirala, Shiva; Neumann, Ralf S; Sandve, Geir K; Sarna, Vikas K; Lundin, Knut Ea; Qiao, Shuo-Wang; Sollid, Ludvig M.
Afiliación
  • Risnes LF; Centre for Immune Regulation, Department of Immunology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.
  • Christophersen A; K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
  • Dahal-Koirala S; Centre for Immune Regulation, Department of Immunology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.
  • Neumann RS; K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
  • Sandve GK; K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
  • Sarna VK; Biomedical Informatics, Department of Informatics, University of Oslo, Oslo, Norway.
  • Lundin KE; K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
  • Qiao SW; Centre for Immune Regulation, Department of Immunology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.
  • Sollid LM; K.G. Jebsen Coeliac Disease Research Centre, Department of Immunology, and.
J Clin Invest ; 128(6): 2642-2650, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29757191

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos HLA-DQ / Enfermedad Celíaca / Receptores de Antígenos de Linfocitos T alfa-beta / Glútenes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos HLA-DQ / Enfermedad Celíaca / Receptores de Antígenos de Linfocitos T alfa-beta / Glútenes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Invest Año: 2018 Tipo del documento: Article